Objective: Mephedrone has been recently made illegal in Europe, but little empirical evidence is available on its impact on human cognitive functions. We investigated acute and chronic effects of mephedrone consumption on drug-sensitive cognitive measures, while also accounting for the influence of associated additional drug use and personality features. 
Introduction
Drugs are feared to threaten our mental health facilitating politics that criminalise their distribution and use (Nutt et al., 2010) . While we increasingly know about the clinical, cognitive, and physical implications when individuals use "conventional" licit and illicit psychoactive substances (Fernández-Serrano et al., 2011, e.g. heroine, cocaine, nicotine; Fernandez-Serrano et al., 2010 , Nutt et al., 2010 , we are yet to accumulate a comparable knowledge on so called "new wave" designer drugs. New wave designer drugs encompass a range of modern psychoactive substances, which have been both specifically marketed and synthesized for the aim of providing an intoxicating high. Since they are new, legislations have not yet been established, making the use of many of these substances officially legal and therefore attractive .
The most popular of these drugs are based on the substance cathinone, a compound found in the khat plant (see Schifano et al., 2010 for overview) . One derivate of cathinone is a substance widely referred to as mephedrone, (colloquially known as "4-MMC, MMCat, Meow/Miaow Miaow, Bubbles, Meph, Rush, Drone, Plant Feeder") which has been relatively popular in the clubbing scene in recent years (Winstock et al., 2011 .
Cathinone substances have a chemical structure similar to amphetamine (Hoffman and Al'Absi, 2010 , Dal Cason et al., 1997 , Prosser and Nelson, 2012 , a similarity that is also reflected in the observation that they seem to mimic the physiological and psychological actions of amphetamines (Kalix, 1992 , Schifano et al., 2010 . For instance, both cathinones and amphetamines prevent the uptake and stimulate the presynaptic release of dopamine, serotonin and noradrenalin (see Kalix, 1992 for overview). Importantly, similarly to amphetamines, high doses of mephedrone can induce hallucinations (ACMD, 2010 , Vardakou et al., 2011 , James et al., 2010 . To assess the physiological and psychological effects of cathinones, Brenneisen et al. and discovered that the drug markedly increased heart rate and blood pressure in comparison to placebo. Furthermore, participants reported an increased sense of euphoria and sociability, which is comparable to independent reports on the psychological effects of mephedrone (Morris, 2010) .
Reports such as these facilitated a fierce debate on the potential risks and harmfulness of mephedrone, and its use was recently made illegal in the UK (see Vardakou et al., 2011 for overview, Winstock et al., 2011 and other European countries (EMCDDA, 2010a , EMCDDA, 2011 , EMCDDA, 2012 .
Despite some scientific explorations on the physiological and psychological effects of cathinones (Brenneisen et al., 1990 , James et al., 2010 , Vardakou et al., 2011 , ACMD, 2010 , Morris, 2010 , studies on the cognitive effects of these substances are surprisingly sparse (Hoffman and Al'Absi, 2010) , and to our knowledge have only recently started to be investigated. For instance, khat use has been found to relate to impairments in working memory and cognitive flexibility (Colzato et al., 2011b) , increased response conflict (Colzato et al., 2012) and decreased inhibitory control (Colzato et al., 2011a) . Given the similarities between amphetamines and cathinones in chemical structure (Dal Cason et al., 1997) and subjective reports (Brenneisen et al., 1990 , James et al., 2010 , Vardakou et al., 2011 , ACMD, 2010 , Morris, 2010 , it seems justified to expect cathinone use to result in similar cognitive peculiarities to those reported after amphetamine use. If this reasoning is indeed considered feasible, we can infer from previous experimental research into the cognitive harms of amphetamines (see Fernández-Serrano et al., 2011 , Kalechstein et al., 2007 for overview) that mephedrone (and other derivates of cathinones) might negatively affect various aspects of cognition such as working memory (Curran and Travill, 1997) (Hanson and Luciana, 2004) , cognitive flexibility , verbal learning (Gonzalez et al., 2004 , Laws and Kokkalis, 2007 , McCardle et al., 2004 , Parrott and Lasky, 1998 , and mood Travill, 1997, Parrott and Lasky, 1998) . Given that these predictions are based on inferences from research on amphetamines, we here aimed to test more directly whether cognitive impairments reported from amphetamine use might also be observed for mephedrone use or other drug use more broadly.
While the question on cognitive impairments as a function of drug use seems straightforward, it misses out on the equally important question on who would be most prone to use such drugs in the first place, or who might have a higher risk of experiencing harmful consequences from drug consumption. Knowing about these influential factors should indeed be of interest to clinicians and society more broadly, because early detection might help reduce negative long-term consequences for mental health (Bird et al., 2010 , Marshall and Rathbone, 2006 , Larsen et al., 2011 . One factor associated with enhanced drug use is schizotypy (see Barkus and Murray, 2010 for overview), a personality construct that has also been associated with an enhanced risk for psychiatric conditions (Chapman et al., 1994 , Gooding et al., 2005 .
Schizotypy is thought to describe subjective experiences in the general population that are reminiscent of those reported from patients with schizophrenia, but in a milder form (Meehl, 1962) . Such similarities are not only evident on the phenomenological level, but are also found for cognitive functions. In more detail, cognitive impairments that are common in patients with psychosis are also found along the psychosis dimension, although less severe, such as in individuals with a schizotypal personality disorder [see Reichenberg & Harvey (2007) for overview], and individuals from the general population scoring relatively high on self-report schizotypy questionnaires (Krabbendam et al., 2005 , Poreh et al., 1995 , Burch et al., 2004 Laurent et al., 2001, Vollema and Postma, 2002) . Most important to the present study, cognitive functions relying on the frontal lobes such as cognitive flexibility (Diforio et al., 2000 , Laurent et al., 2000 , Voglmaier et al., 1997 , Blanchard et al., 2010 , working memory (Voglmaier et al., 1997 , Voglmaier et al., 2005 , Park and McTigue, 1997 , Kopp et al., 2002 , verbal memory (Kaczorowski et al., 2009 , Burch et al., 2006 and verbal fluency (Laurent et al., 2000, Tsakanikos and seem attenuated along the psychosis spectrum including schizotypy (see also Reichenberg and Harvey, 2007 for overview) .
A potential problem of the above described literature is that only few investigated cognition, drug use and schizotypy simultaneously, i.e. studies either investigated the influence of a particular drug on cognition, the link between drug use and schizotypy, or the relationship between schizotypy and cognitive functioning. Yet, in the latter case, individuals with elevated schizotypy are also likely to be subject to relative enhanced polydrug use, without this drug consumption being accounted for. We found 14 studies investigating the link between schizotypy and cognitive flexibility, verbal memory and verbal fluency; seven of them did not report on drug use (Laws et al., 2011 , Giraldez et al., 1999 , Dinn et al., 2002 , Lenzenweger and Korfine, 1994 , Park et al., 1995 , Tsakanikos and Claridge, 2005 , Burch et al., 2006 , and the others varied in their drug control criteria (Poreh et al., 1995 , Daneluzzo et al., 1998 , Kim et al., 2011 , Suhr, 1997 , Koychev et al., 2011 , Kaczorowski et al., 2009 , Matheson and Langdon, 2008 . It is thus possible that substance use (e.g. illicit as well as licit substances) influenced the relationship between schizotypal symptoms and the cognitive functions assessed (Herzig et al., 2010, Herzig and . As will be shown in the following, the present study took this reasoning into account. We investigated the potential role of current mephedrone use (but also of other common drugs) on cognitive functioning, and how this relationship might be influenced by individuals'
schizotypy. In particular, we adopted a "natural" design in which a group of participants was tested twice, before (pre-clubbing) and after (post-clubbing) their clubbing experience. Because mephedrone was a preferred clubbing drug at the time of testing, we expected that some participants would consume new wave designer drugs such as mephedrone. This experimental design not only allowed to account for changes of cognitive functioning over the course of a clubbing experience (short-term) but also whether individuals using mephedrone have a more severe overall drug history (polydrug use) potentially implying that their cognitive functioning is already relatively impaired at the pre-clubbing stage (long-term effects).
Given the similarity between the physiological and emotional effects of cathinones and amphetamines, we predict that mephedrone users as compared to non-users should show relatively impaired cognitive functioning as reported from amphetamine users (cognitive flexibility, verbal learning and verbal fluency). Moreover, we considered the possibility that drug use rather than schizotypy would be the dominant predictor of these relatively impaired cognitive functions (Herzig et al., 2010, Herzig and . Because of the reported links between various drugs of abuse, mood and sleep patterns on cognition we also controlled for possible influential variables such as depression (Deykin et al., 1987 , Davison and Parrott, 1997 , Curran and Travill, 1997 , MacInnes et al., 2001 ) and sleep Travill, 1997, Carhart-Harris et al., 2008) . By accounting for these variables a 'purer' measure of the effects of drug use on cognition is expected to derive. To ensure groups were matched on IQ, participants completed the NART at the beginning of the pre-clubbing session. The NART is designed to provide a measure of verbal IQ, through the visual presentation of a list containing 50 irregular words, which the participant is required to pronounce in serial order (Nelson, 1982) . The NART is a widely used and reliable test that takes advantage of the correlation between reading ability and intelligence in the normal population (Wiens et al., 1993) . The greater the number of correctly pronounced words the higher a Badcock et al. (2011) .
Methods

Participants
Verbal fluency (COWAT)
The COWAT (Controlled Word Association Task) was originally developed by Bechtold, Benton et al. (1962) , and is a measure of left frontal lobe functioning (Newman et al., 2007 , Wood et al., 2001 . It tests participants' ability to produce as many words as they can that begin with pre-determined sequentially presented letters (in this study: F, A and S) or categories (in this study: animals, vegetables and fruit) within a minute. In the present study, only letters were presented. We assessed the number of correctly generated words across all three letters. Proper nouns and changing of suffixes and prefixes were not included (for example 'See' would be correct but subsequently saying 'seeing' would not). The test has been found to have reasonable test-retest reliability (Ruff et al., 1996) , and updated normative data can be found in Ruff et al. (1996) .
Trail making task (TMT)
The TMT is used to test cognitive flexibility. It was originally part of the Army Individual Test
Battery (1944), and was incorporated into the Halstead-Reitan Battery (Reitan and Wolfson, 1985) . In the TMT participants are presented with a sheet of paper depicting circles. These (Lezak, 1995) adjusted for individual differences in motor functioning and visual search strategies (Reitan and Wolfson, 1985) . Norm values are available from Tombaugh (2004) .
Questionnaires
The Beck Depression Inventory (BDI)
The BDI (Beck et al., 1961 ) is a 21 item questionnaire designed to measure depressive (Sotiropoulos et al., 2008 , Beck et al., 1961 . In this experiment, we asked participants to answer the questionnaire by referring to how they generally felt in the past two weeks (pre-clubbing) and to how they feel currently (post-clubbing).
The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE; short version)
The short O-LIFE questionnaire (Mason et al., 2005 ) is a validated 43-item self-report questionnaire assessing schizotypy in terms of four dimensions. Positive schizotypy is assessed by 12 items pertaining to Unusual Experiences (UnEx, maximum score 12, including items such as 'Are your thoughts sometimes so strong that you can almost hear them?'), negative schizotypy is assessed by 10 items pertaining to Introvertive Anhedonia (IntAn, maximum score 10, including items such as 'Do you prefer watching television to going out with people?'), and Cognitive Disorganization is assessed by 11 items (CogDis, maximum score 11, including items such as 'Are you easily confused if too much happens at the same time?'). Finally, 10 items assess Impulsive Nonconformity (ImpNC, maximum score 10), which does not represent a schizotypy dimension (Mason et al., 1995) , but will be accounted for in the present study because of the significant link between impulsivity and addiction (Crews and Boettiger, 2009 ).
For each item, participants have to indicate whether the statement is true or false. The number of positive responses (some items are reversely formulated) is summed so that higher scores indicate higher schizotypy. Normative values can be found in Mason et al. (2005) and the scale has shown good internal consistency as well as high correlations with the original O-LIFE questionnaire (Mason et al., 2005 , Mason et al., 1995 . On the post-clubbing testing session participants were asked to fill in the drug questionnaires of the national household survey on drug abuse (NHSDA; 1998). The NHSDA questionnaire gives detailed data of respondents' prior drug use, and an adapted version was administered to assess use of nicotine, alcohol, cannabis, mephedrone, amphetamine, cocaine, ketamine and benzodiazepine use during the clubbing experience (amount used), and in the past 30 and seven days (times used). Additionally, participants indicated their total amount of average hours of sleep, as well as how much they slept between the pre-and the post-clubbing experience (total amount of hours).
Data analysis Mephedrone use vs. Control
In a first set of analysis, in which we focused on recent mephedrone use, we calculated separate 2 x 2 mixed sample ANOVAs with day (pre-clubbing, post-clubbing) as the related samples factor and drug use group (mephedrone, control) as the independent samples factor on the total % correct responses in the RAVLT (measuring verbal learning) as well as total amount correct items named in the COWAT (measuring verbal fluency). In the TMT (measuring cognitive flexibility) an index (TMT B -TMT A) was calculated and used as an outcome measure, with higher values indicating reduced cognitive flexibility. Post-hoc tests were performed using paired samples tests. Effect sizes are reported for all ANOVA results.
In order to establish if schizotypy explained an additional amount of variance on top of drug use and demographic / control variables, we firstly explored which variables are relevant to the regression models. We correlated age, BDI scores, hours of sleep (average and total hours between pre-and post-clubbing), NART-scores, drug use variables and schizotypy sub-scale variables that were significantly related to at least one outcome measure. Subsequently, two separate regression models were run, corresponding to the two times of assessment (see result section for details). Blocks of predictors were entered into the regression model, with the first one containing control variables (if none of these correlated with the outcome measures, this step was omitted), the subsequent step including drug use information, and the final step containing schizotypy measures. These blocks were entered in nested blocks, meaning that each subsequent block contained all prior predictors and the additional predictors from the current block.
Presentation of results however will only include significant predictors as in Fridberg et al. (2011) , for economy of presentation. Because all tolerance values were above .2 (Menard, 1995) , and all independent variables were mean-centered, multi-collinearity between the independent variables was considered negligible. The dependent variables were i) total percentage correctly recalled items in the RAVLT, for immediate and delayed recall, ii) the total amount of correctly named items in the verbal fluency task, and iii) TMT index scores.
Kolmogorov-Smirnov tests for the groups separately revealed normal distribution for all behavioral measures, NART, BDI and schizotypy scores. All p-values were two-tailed and the α-level was set at .05.
Results
Participants and self-report questionnaires
The first major analysis concerned the grouping of people in the mephedrone and control group.
Of the 26 participants, 10 reported having used mephedrone between test sessions. In the 30 days prior to testing, eight of the 10 mephedrone users reported having used nicotine, one had used cannabis, eight had used alcohol, and four had used amphetamines. In the 30 days prior to testing, 14 of the 16 non-mephedrone using controls used alcohol, four had used cannabis and five had used nicotine.
In the seven days prior to testing, only one mephedrone user had used amphetamines and cannabis once. For all other mephedrone users recency of use for other illicit substances (including mephedrone) exceeded seven days. None of the mephedrone non-users had used cannabis or other illicit substances within the last seven days prior to testing.
As is evident from Table 1 , mephedrone users used more amphetamine, mephedrone, and nicotine as compared to the control group in the past 30 days, more nicotine in the past seven days prior to testing, and more mephedrone and alcohol during the clubbing experience.
Furthermore, mephedrone users as compared to controls scored higher on BDI scores, CogDis and ImpNC. A mixed-samples ANOVA with BDI scores pre-clubbing and post-clubbing as the repeated measures, and group (mephedrone, control) as the between subjects factor indicated that there was a significant effect of day of testing [F(1,24)=6.69, p=.02, partial η 2 = .22], with BDI scores being generally lower pre-clubbing than post-clubbing (see Table 1 ). There also was a significant interaction between group * day of testing [F(1,24)=17.83, p<.001, partial η 2 = .43].
Post-hoc paired samples t-tests split by group revealed that this rise in BDI scores was only significant in the mephedrone using group [t(9)=-3.70, p<.01], but not in the control group [t(15)= 1.50, p=.16; see Table 1 ]. All other measures did not differ between groups (Table 1 ).
- Table 1 about here- Table 2 ). The interaction between group and day (F(1,24)= .85, p= .37, partial η 2 = .03) and the effect of day (F(1,24) = 1.99, p = .17, partial η 2 = .08; see Table 2 ) were both not significant. For the delayed recall measure, we found that mephedrone users performed significantly worse than controls (F(1,24) = 12.33, p < .01, partial η 2 = .34; see Table 2 ). Whereas the effect of day (F(1,24) = .73, p = .40, partial η 2 = .03;
Results in the behavioural tasks
see Table 2 ) was not significant, the analysis revealed a significant interaction between group and day (F(1,24) = 7.72, p = .01, partial η 2 = .24). Post-hoc paired samples t-tests split by group revealed that in the control group there was no difference in scores between pre-and post clubbing [t(15) = -1.30, p = .21]. However, the mephedrone group showed a significant decrease in delayed recall performance between pre-and post-clubbing [t(9) = 4.33, p < .01; see Table 2 ].
- Table 2 about here-
COWAT
There was a significant main effect for group (F(1,24) = 5.32, p = .03, partial η 2 = .18), with mephedrone users performing significantly worse than controls (see Table 2 ). Additionally, there was a significant effect of day (F(1,24) = 6.77, p = .02, partial η 2 = .22; see Table 2 ), and interaction between group and day (F(1,24) = 13.11, p < .01, partial η 2 = .35). Post-hoc paired samples t-tests split by group revealed that in the mephedrone group values significantly decreased from pre-to post-clubbing [t(9) = 5.00, p < .01; see Table 2 ), whereas there was no day difference in the control group [t(15) = -.74, p = .47; see Table 2 ). Table 2 ).
TMT
Regressions: Severity of drug use and schizotypy as predictors of performance
To further investigate the possibility that schizotypy may be relevant to cognitive functioning on top of drug use, multivariate step-wise regressions were conducted. Exploratory correlation analyses (Table 3) showed that pre-clubbing amphetamine, mephedrone and cannabis use in the past 30 days, as well as CogDis scores correlated with cognitive functioning. Therefore, for the pre-clubbing session amphetamine, mephedrone and cannabis use in the past 30 days was entered in the first step, and CogDis scores in the second step.
- Table 3 about hereFor the post-clubbing session (Table 4) BDI scores, total hours of sleep between test sessions, mephedrone use and schizotypy scores (UnEx, CogDis and ImpNC scores) were correlated with at least one of the outcome measures. Therefore, BDI scores post-clubbing and total hours of sleep between test sessions were entered in the first step, mephedrone use between test sessions in the second, and schizotypy subscales (UnEx, CogDis and ImpNC) in the third step.
- Table 4 about here-
The results from the regression on pre-clubbing session are displayed in Table 5 . We found that immediate recall in the RAVLT was reduced with increasing cannabis use and delayed recall in the RAVLT was reduced with increasing amphetamine use. Additionally, increasing CogDis scores related to a decreasing number of words produced in the COWAT.
- Table 5 about here-
The results from the regression on post-clubbing session are presented in Table 6 . Results indicate that increasing BDI scores predicted lower RAVTL performance (immediate and delayed recall) as well as less words produced in the COWAT. Additionally, a higher amount of hours slept between test-sessions related to lower immediate recall performance in the RAVTL and less words produced in the COWAT. Adding drugs or schizotypy in later steps did not explain additional variance in cognitive functioning.
- Table 6 about here-
Discussion
Drug policies are aimed to prevent harm to people by making access to these drugs more difficult. To avoid the problem of the illegality of drugs, new drugs are frequently developed that are little or not yet regulated. Among those drugs are popular new wave designer drugs such as mephedrone. These provide "legal highs" without knowing much about their harmfulness or factors that might predict it. We here investigated whether mephedrone use might have a negative impact on cognitive functioning, and whether any such relationship might be influenced by individuals' schizotypal features and other drug use. We tested cognitive functions that were formerly associated with amphetamine use and elevated schizotypy, i.e. cognitive flexibility, verbal learning and verbal fluency. Importantly, we were able to recruit volunteers in a "natural" setting, i.e. before and after a clubbing experience during which drugs such as mephedrone are baseline functioning (i.e. the cognitive level at which individuals with different drug histories entered the study), and ii) how the drug use of the clubbing experience affected their cognitive performance (i.e. short-term effects). The main findings of the present study were that i) mephedrone users performed worse than controls at baseline and their performance decreased pre-to post-clubbing in tasks measuring cognitive functioning, ii) cannabis and amphetamine use related to decreased cognitive performance in the pre-clubbing session, whereas mephedrone did not, iii) depression rather than drug use or schizotypy was the most consistent predictor of cognitive attenuations in the post-clubbing session, and iv) schizotypy did not explain variance in cognitive functioning (apart from CogDis in the pre-clubbing session) when controlling for drug use. These findings will be discussed in the following sections.
We argued that the cognitive consequences of mephedrone use should mirror those of amphetamine use, because studies reported on physiological, chemical and psychological similarities between the consequences of amphetamine (such as ecstasy) and cathinone use (Dal Cason et al., 1997 , Kalix, 1992 , Schifano et al., 2010 , ACMD, 2010 , Vardakou et al., 2011 , James et al., 2010 , Morris, 2010 , Brenneisen et al., 1990 , Hoffman and Al'Absi, 2010 . For our pre-clubbing session, we observed that mephedrone users performed worse than the control group for immediate and delayed verbal recall, and verbal fluency. Our group results also showed that performance in all but the TMT task became worse over the preclubbing to post-clubbing session in our mephedrone users as compared to controls. These group comparison results would suggest that recent mephedrone use negatively affects cognitive Firstly, we found that mephedrone users as compared to controls had consumed more amphetamines and nicotine in the 30 days prior to testing. Secondly, when looking at the individual contribution of drug use (regression analysis) on cognitive functioning, we found that enhanced cannabis and amphetamine use was related to memory impairments, whereas mephedrone use was not. These latter results are in line with studies on the cognitive effects of amphetamines (Hoshi et al., 2007 , Morgan, 2000 Polydrug use and not only single drug use might be relevant for cognition and mood in the short-term, as was found here when considering post-clubbing performance and mood. In the regression analysis, we explored additional factors that could influence cognitive measures postclubbing more thoroughly. Strikingly, we found that higher BDI scores and prolonged sleep (rather than drug use or schizotypy) predicted a relative drop in cognitive performance. While not our a priori focus, the role of depression is worthwhile considering. To start with, our mephedrone users as compared to controls showed higher BDI scores both pre-clubbing and post-clubbing. Moreover, schizotypy scores showed no additional influence on cognitive functioning post-clubbing, and the influence of actual drug use seemed to become marginal when BDI scores were considered. We thus conjecture that depression might be a major confound in previous schizotypy and drug studies that targeted cognitive functions, because depression levels are commonly not assessed (e.g. Herzig et al., 2010 , Skosnik et al., 2001 . The same can be said (Fried et al., 2005) , alcohol users (Ratti et al., 2002) or psychostimulant users (Bolla et al., 2003) . Depression rates are, however, relatively elevated in e.g. amphetamine users (Morgan, 2000 , Rogers et al., 2009 for overview), alcohol users and cannabis users (Hayatbakhsh et al., 2007 , Patton et al., 2002 .
Consequently, if depression is a major confound in studies such as the present one, we would expect that depression influences cognitive functioning directly (primary influence) or indirectly (secondary influence through e.g. loss of motivation), much as we have originally expected this to be the case for drug use and / or schizotypy.
Studies that tested the link between depression and cognitive functioning indeed report that clinical depression in young adults is accompanied by relatively impaired cognitive functioning including those we tested here (see Castaneda et al., 2008 for overview) . Even in healthy subjects, negative mood can lead to reduced brain activity during verbal (not spatial) working memory tasks (Aoki et al., 2011) . Finally, the mood-behavior model (Gendolla, 2000) predicts that negative mood results in disengagement and little resource mobilization when facing difficult tasks, as demands would be perceived as being too high (Silvestrini and Gendolla, 2009 ). Given that negative mood is frequently a characteristic of depression, it is possible that task performance decreases the more individuals are depressed, due to decreased motivation (Locke and Braver, 2008, Engelmann et al., 2009 ). Another possibility, though not necessarily independent of motivational factors, could be that the clubbing experience (including the drug consumption) resulted in neurochemical changes related to depression via serotonergic pathways, or more specifically through an attenuation of serotonergic functioning (Bhagwagar et al., 2006 , Meyer et al., 2003 , Meyer et al., 2004 .
Serotonin is a neurotransmitter, importantly linked to depression, to amphetamine use (see Walstab et al., 2010 for overview) , and the interaction between depression and amphetamine use (see Darke et al., 2008 for overview, McCardle et al., 2004 , Rogers et al., 2009 , Morgan, 2000 .
In all cases, a reduction in serotonin availability seems to have negative consequences. For instance, taking amphetamines such as ecstasy is related to a drop in mood, observable about two days after its consumption Travill, 1997, Parrott and Lasky, 1998) , presumably via reductions in serotonin-receptor density and binding [McCann et al. (1998 [McCann et al. ( , 2008 ]. These changes in serotonin functioning have also been related to verbal memory performance (Reneman et al., 2001) . Interestingly, serotonin receptor functioning has been implicated in the rewarding effects of THC as well (Maldonado et al., 2011) , and some studies suggest that the effect of amphetamine and cannabis on memory functions is accumulative when consumed in parallel (see Mohamed et al., 2011 for overview) . Taken together, these findings suggest that amphetamine and cannabis use may have altered susceptibility to mood-related cognitive attenuations, either via motivational factors, neurochemical modulations, or both.
To summarize, drug use was a consistent predictor of task performance in the long-term (preclubbing), and may have induced mood-related attenuations in cognitive functioning in the shortterm (post-clubbing). Schizotypy, on the other hand, was largely irrelevant to cognitive functioning on top of (poly-)drug use. The only significant schizotypy finding was that enhanced CogDis scores related to reduced verbal fluency. If we consider this single significant finding to be meaningful, the question arises whether some schizotypy dimensions are pathologically more relevant than others. Indeed, several researchers have indicated that CogDis is related to.
unpleasant evaluation of unusual experiences (Schofield and Claridge, 2007) , or cognitive attenuations and poor emotional processing (Kerns and Becker, 2008, Cappe et al., 2012) . A problem is certainly the lack of consideration of disorganised symptoms in studies that found attenuated cognitive functioning relating to positive symptoms (Laws et al., 2011, Lenzenweger and Korfine, 1994) , and that most of the psychometric tools used in these studies do not distinguish between the two symptom dimensions (Chapman et al., 1976 , Eckblad and Chapman, 1983 , Chapman et al., 1978 , Eysenck and Eysenck, 1975 , Winterstein et al., 2011 , Peters et al., 1999 .
If cognitive disorganisation is considered to be a separate symptom dimension, it seems more relevant to cognitive performance than the positive symptom dimension. For instance, in a study by Rawlings and Goldberg (2012) performance in a continuous performance task was affected by higher cognitive disorganization, but not as consistently by other schizotypy dimensions.
Similar conclusions on the role of symptom dimensions have also been drawn from studies in other schizotypal samples (Szöke et al., 2009 , Chan et al., 2011 , Colzato et al., 2011a , Cappe et al., 2012 and in schizophrenia patients (Kebir et al., 2008 , Lucas et al., 2004 . With regard to schizotypy, positive symptoms have even been associated with performance benefits such as in creativity tasks (Nelson and Rawlings, 2010 , Mohr et al., 2001 , Batey and Furnham, 2008 . It might be the case that scoring high on positive schizotypy only relates to a well-adapted cognitive profile, while high scores in CogDis alone or in combination with high scores in positive schizotypy might yield the most disadvantageous cognitive profile (Schofield and Claridge, 2007, Cappe et al., 2012) . Our results would support this notion.
Study limitations and implications
Our study population consisted of volunteers who were willing to come to the laboratory twice, shortly before and after a clubbing night. Moreover, testing had to be completed within two months. These study constraints reduced the number of possible participants, and by inference the overall sample size. Given our naturalistic designs, we nevertheless argue that our results are informative (Fernández-Serrano et al., 2011) , and stress that we could retain a considerable number of participants despite their clubbing activity, and decreased mood. These volunteers committed themselves to be tested twice around their clubbing experience, turning this sample and the measurements into a valuable data pool. Only with this naturalistic design were we able to assess the long-term (pre-clubbing) and short-term (post-clubbing) effects of drug use as it might occur in everyday situations. We suggest that the current study, its design and results revealed important new findings that should be followed up in future studies, including laboratory ones (the role of depression, mediation of results by the emotional consequences of the clubbing / drug experience not observable in laboratory tests of drug exposure, the problem of poly-drug use).
Illicit drug use and depression are associated, but so are licit drugs. For instance, alcohol negatively influences mood, and the accumulation of this effect could be related to the depression rate increase seen in mephedrone users as well. According to recent meta-analyses, alcohol increases the risk for depression (Boden and Fergusson, 2011) , is related to impairments Fernández-Serrano et al., 2011 for overview, Zeigler et al., 2005 , Manning et al., 2008 , Wendt and Risberg, 2001 , and hangovers are usually associated with low mood (Howland et al., 2010) . Moreover, alcohol seems to affect serotonin-receptor functioning, similarly to amphetamines (McHugh et al., 2010 , Vengeliene et al., 2008 . Given that alcohol has been used more frequently between test sessions in mephedrone users, we assume important interaction effects with alcohol.
It is also possible that the effects of mephedrone become more pronounced in chronic users, or those that use the drug at a high frequency, as in our sample use was relatively low (about 1.5 times/month). Another possibility is that unreported (intentionally taken) or unknown (e.g. participants consumed impure mephedrone) substances were taken, influencing cognitive performance. We did not confirm individuals' self-report with objective drug tests. (MacCabe and Murray, 2004 , Moore et al., 2007 , Sørensen et al., 2010 or substance use (Pope et al., 2003 , Zammit et al., 2010 . However, in our sample most participants were students, or educated to at least degree level. Therefore, more variance in subjects' educational level/IQ could be informative in subsequent studies.
Conclusion
We set out to investigate the effects of mephedrone use on cognition, and elucidate the relationship between drug use, schizotypal symptoms and cognitive functioning. Results showed that even before clubbing (and after recent drug use) mephedrone users performed worse than non-users on cognitive tasks. In mephedrone users but not in controls, performance in verbal learning and fluency decreased over the clubbing experience. Additional analysis on the use of other drugs and psychological factors, however, indicated that the changes in cognitive functioning were likely due to prior polydrug use (amphetamine, cannabis and alcohol use in particular), and related psychological consequences (enhanced depression rates). Schizotypal traits were rather unrelated to cognitive performance, apart from CogDis. This schizotypy subscale may therefore represent a pathologically more relevant symptom dimension. The present study shows that polydrug use should be considered in future studies on drug effects on cognition, as well as relevant associated psychological concepts (depression, schizotypy). Given the political interest in preventing the population from harmful drug effects, knowing which conditions increase risk is warranted, particularly because a more regulated drug policy has been called for from various professional domains (Nutt et al., 2010, Bennett and Holloway, 2010 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
